GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precigen Inc (FRA:I5X) » Definitions » Cyclically Adjusted PB Ratio

Precigen (FRA:I5X) Cyclically Adjusted PB Ratio : 0.43 (As of May. 21, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Precigen Cyclically Adjusted PB Ratio?

As of today (2024-05-21), Precigen's current share price is €1.258. Precigen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €2.92. Precigen's Cyclically Adjusted PB Ratio for today is 0.43.

The historical rank and industry rank for Precigen's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:I5X' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.3   Med: 0.4   Max: 0.65
Current: 0.43

During the past years, Precigen's highest Cyclically Adjusted PB Ratio was 0.65. The lowest was 0.30. And the median was 0.40.

FRA:I5X's Cyclically Adjusted PB Ratio is ranked better than
75.93% of 648 companies
in the Biotechnology industry
Industry Median: 1.745 vs FRA:I5X: 0.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Precigen's adjusted book value per share data for the three months ended in Mar. 2024 was €0.357. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.92 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Precigen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Precigen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precigen Cyclically Adjusted PB Ratio Chart

Precigen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.49 0.41

Precigen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.33 0.42 0.41 0.45

Competitive Comparison of Precigen's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Precigen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precigen's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precigen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Precigen's Cyclically Adjusted PB Ratio falls into.



Precigen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Precigen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.258/2.92
=0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precigen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Precigen's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.357/131.7762*131.7762
=0.357

Current CPI (Mar. 2024) = 131.7762.

Precigen Quarterly Data

Book Value per Share CPI Adj_Book
201406 2.775 100.560 3.636
201409 2.767 100.428 3.631
201412 3.103 99.070 4.127
201503 5.455 99.621 7.216
201506 3.856 100.684 5.047
201509 5.500 100.392 7.219
201512 5.462 99.792 7.213
201603 5.081 100.470 6.664
201606 4.660 101.688 6.039
201609 4.517 101.861 5.844
201612 4.475 101.863 5.789
201703 4.134 102.862 5.296
201706 4.072 103.349 5.192
201709 3.712 104.136 4.697
201712 3.693 104.011 4.679
201803 3.471 105.290 4.344
201806 3.636 106.317 4.507
201809 3.371 106.507 4.171
201812 1.993 105.998 2.478
201903 1.725 107.251 2.119
201906 1.526 108.070 1.861
201909 1.276 108.329 1.552
201912 0.395 108.420 0.480
202003 0.463 108.902 0.560
202006 0.255 108.767 0.309
202009 0.278 109.815 0.334
202012 0.294 109.897 0.353
202103 0.711 111.754 0.838
202106 0.640 114.631 0.736
202109 0.540 115.734 0.615
202112 0.460 117.630 0.515
202203 0.323 121.301 0.351
202206 0.253 125.017 0.267
202209 0.692 125.227 0.728
202212 0.573 125.222 0.603
202303 0.673 127.348 0.696
202306 0.600 128.729 0.614
202309 0.540 129.860 0.548
202312 0.437 129.419 0.445
202403 0.357 131.776 0.357

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precigen  (FRA:I5X) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Precigen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Precigen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precigen (FRA:I5X) Business Description

Industry
Traded in Other Exchanges
Address
20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Precigen (FRA:I5X) Headlines

No Headlines